Login to Your Account



BIO-Europe 2011

Staying Positive in the Gloom; European Biotechs Muddle Through Despite Lack of VC

By Cormac Sheridan
BioWorld Today Correspondent

Thursday, November 3, 2011

DUSSELDORF, Germany – BIO-Europe Fall 2011 entered its final day as Europe's financial system teetered on the brink – yet again – following Greece's shock decision to put its recently agreed bailout package to a popular vote. Although the issues facing Europe's biotechnology industry seem pretty minor in comparison, a definite sense of gloom has pervaded many of the discussions here at BIO-Europe.

For all but the chosen few who have secured the best investment deals and the juiciest alliances, conditions are far from ideal.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription